Literature DB >> 12036900

Human acute stem cell leukemia with multilineage differentiation potential via cascade activation of growth factor receptors.

Ugo Testa1, Giovanni F Torelli, Roberta Riccioni, Andrea Onetti Muta, Stefania Militi, Luciana Annino, Gualtiero Mariani, Anna Guarini, Sabina Chiaretti, Jerome Ritz, Franco Mandelli, Cesare Peschle, Robin Foa.   

Abstract

The morphologic, immunophenotypic, genotypic, genomic, and functional features of an undifferentiated acute leukemia with stem cell features are reported. At light and electron microscopy, the leukemic population was represented by primitive progenitor cells with no evidence of differentiation. The blasts were CD34(+), AC133(+), CD71(-), HLA-DR(-), CD38(-/dim+), CD90(+), CD117(dim+), flt3(+); did not express B, T, or myeloid-associated antigens; and showed a germline configuration of the immunoglobulin and T-cell receptor. Genomic profiling documented the expression of early stem cell and myeloid-associated genes. Receptors for early-acting hemopoietic growth factors (HGFs) were detected, while receptors for unilineage HGF were not expressed. Incubation with the flt3 or Kit ligand induced the expression of unilineage HGF receptors, allowing these cells to respond to their respective ligands. Growth without differentiation was sustained only in the presence of early-acting HGF, namely flt3 ligand, while early and unilineage HGF gave rise to all types of hemopoietic colonies.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12036900     DOI: 10.1182/blood.v99.12.4634

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  6 in total

1.  In situ-synthesized novel microarray optimized for mouse stem cell and early developmental expression profiling.

Authors:  Mark G Carter; Toshio Hamatani; Alexei A Sharov; Condie E Carmack; Yong Qian; Kazuhiro Aiba; Naomi T Ko; Dawood B Dudekula; Pius M Brzoska; S Stuart Hwang; Minoru S H Ko
Journal:  Genome Res       Date:  2003-05       Impact factor: 9.043

2.  High CD123 levels enhance proliferation in response to IL-3, but reduce chemotaxis by downregulating CXCR4 expression.

Authors:  Nicole L Wittwer; Gabriela Brumatti; Ceilidh Marchant; Jarrod J Sandow; Melanie K Pudney; Mara Dottore; Richard J D'Andrea; Angel F Lopez; Paul G Ekert; Hayley S Ramshaw
Journal:  Blood Adv       Date:  2017-06-20

3.  Overcoming the Immunosuppressive Tumor Microenvironment of Hodgkin Lymphoma Using Chimeric Antigen Receptor T Cells.

Authors:  Marco Ruella; Michael Klichinsky; Saad S Kenderian; Olga Shestova; Amy Ziober; Daniel O Kraft; Michael Feldman; Mariusz A Wasik; Carl H June; Saar Gill
Journal:  Cancer Discov       Date:  2017-06-02       Impact factor: 39.397

4.  Dual CD19 and CD123 targeting prevents antigen-loss relapses after CD19-directed immunotherapies.

Authors:  Marco Ruella; David M Barrett; Saad S Kenderian; Olga Shestova; Ted J Hofmann; Jessica Perazzelli; Michael Klichinsky; Vania Aikawa; Farzana Nazimuddin; Miroslaw Kozlowski; John Scholler; Simon F Lacey; Jan J Melenhorst; Jennifer J D Morrissette; David A Christian; Christopher A Hunter; Michael Kalos; David L Porter; Carl H June; Stephan A Grupp; Saar Gill
Journal:  J Clin Invest       Date:  2016-08-29       Impact factor: 14.808

5.  Overexpression of CD123 correlates with the hyperdiploid genotype in acute lymphoblastic leukemia.

Authors:  Miroslav Djokic; Elisabet Björklund; Elisabeth Blennow; Joanna Mazur; Stefan Söderhäll; Anna Porwit
Journal:  Haematologica       Date:  2009-05-19       Impact factor: 9.941

Review 6.  Flt3 in acute myelogenous leukemia: biology, prognosis, and therapeutic implications.

Authors:  Ioannis A Voutsadakis
Journal:  Med Oncol       Date:  2003       Impact factor: 3.064

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.